FDABridge
← Retour au blog
Général

FDAストーリー #016 — エジプトのナツメヤシ輸出業者のPrior Noticeに誤ったFDA登録番号があった

製品は'エネルギーを高め、免疫機能をサポートする'と主張していました。これらは構造/機能表示です。製品にはNutrition FactsではなくSupplement Factsパネルが必要でした。

Équipe FDABridge1 janv. 20263 min de lecture

A matcha company in Uji, Kyoto, produced a premium ceremonial-grade matcha powder that they sold in Japan as a traditional tea. When they expanded to the US, their American distributor suggested adding health claims to the marketing: 'Boosts energy naturally,' 'Supports immune function,' 'Rich in antioxidants for cellular health.'

The product was labeled as a food with a Nutrition Facts panel. The marketing materials — on the website, on Amazon, and on shelf talkers — contained structure/function claims.

問題

Under US law, a product that makes structure/function claims — claims about how a substance affects the structure or function of the body — is either a dietary supplement (if it contains a dietary ingredient and is intended for ingestion) or a drug (if the claims go further into disease treatment). A conventional food cannot make structure/function claims without triggering reclassification. 'Boosts energy' and 'supports immune function' are structure/function claims that pushed the matcha from the food category into the dietary supplement category.

As a dietary supplement, the product needed a Supplement Facts panel (not Nutrition Facts), the required disclaimer ('This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease'), a structure/function claim notification filed with the FDA within 30 days of first marketing, and facility registration under the dietary supplement CGMP requirements of 21 CFR Part 111.

解決策

The company had two paths. They could remove all structure/function claims and sell the matcha as a conventional food — which would require only the standard food facility registration and a Nutrition Facts panel. Or they could keep the claims and comply with dietary supplement regulations. They chose to sell the matcha as a conventional food in retail stores (no health claims) and as a dietary supplement through their e-commerce channel (with compliant claims and labeling). Two SKUs. Two labels. Two regulatory pathways from the same facility.

If your product is a tea, powder, extract, or botanical and you want to make health-related claims in the US — you are almost certainly selling a dietary supplement, not a food. The labeling, registration, and compliance requirements are different. Get it right before you launch. fdabridge.com/contact.

Besoin d'aide pour la suite ?

Need help choosing a service?

Compare the main service options and choose the filing path that fits your product category.

À lire aussi

Articles connexes

Général

Symboles de marquage des dispositifs médicaux: Ce que les fabricants étrangers doivent savoir pour entrer sur le marché américain

28 avr. 2026

L'étiquetage des dispositifs médicaux aux États-Unis nécessite des symboles spécifiques pour une bonne communication. Les fabricants étrangers doivent comprendre les normes de symboles acceptées par la FDA avant d'exporter les appareils sur le marché américain.

Lire la suite →
Général

Enregistrement des dispositifs médicaux pour les fabricants étrangers: Un guide du système de réglementation américain

26 mars 2026

Les fabricants étrangers de dispositifs médicaux doivent enregistrer leurs établissements, répertorier leurs dispositifs et, selon la classe de dispositifs, obtenir l'approbation ou l'approbation de la FDA avant de les distribuer aux États-Unis.

Lire la suite →
Général

Dix questions à se poser avant d'embaucher un consultant de la FDA

24 mai 2026

Le choix d'un fournisseur de services de conformité de la FDA est une décision conséquente. Ces dix questions aident les fabricants étrangers à séparer les consultants compétents de ceux qui vont créer des problèmes qu'ils ne peuvent pas résoudre.

Lire la suite →